Health

The CDC's 4,588 count passed twice 2025's total by 10 cases. What it compares, where the cases sit, and what it means for a family, a pregnancy or a trip.

The headline figure is a yearly 3.7% gap in heart failure admissions. The paper's own tables turn it into single digits per 100,000 residents, across a whole region rather than among cannabis users.

The first Ebola vaccine trial in Congo's Bundibugyo outbreak offers every volunteer the candidate within about a month, which keeps the blinded comparison short. Here is what that design can and cannot show.

The headline 42% blends a flat first six months with a later effect. In people, the companies' two-year figures mean about 12 more per 100 recurrence-free, with survival still unknown.

Of 11,380 people in an Australian depression cohort, 2,604 met at least three of six self-reported sleep-and-clock features. The study measured no body clock, and its treatment signal is a modest self-rating of antidepressants.

Congenital measles is alarming but narrow: the baby's risk hinges on a mother's rash near delivery, and each protective step has its own deadline. What Pennsylvania doctors were told, and what no one has counted.

Kenya's eighth Ebola case was found in quarantine, like six before it. The pattern is reassuring, but it rests on a list of about 130 people and a window that closes around Oct. 26.

The headline figures are real UKHSA numbers, but read against last autumn and their own definitions they tell a calmer story. What they count, how to read them, and who should book a jab.

ACOG calls hormone therapy a strong recommendation for hot flashes, with moderate evidence behind it. Here are the risks per 1,000 women, who should skip it, and how the patch shortage changes the choice.

The Eagles say Jalen Hurts' clot is superficial but showed movement on a second scan. Trial numbers show what that can mean, and what nobody outside the team knows.

Atrium promised State Health Plan members copays below the Plan's cheapest tier. Now that most Atrium care is out of network, the Plan pays almost nothing on most bills, and that promise is all that stands between members and its steepest schedule.

Last winter was H3N2; this autumn nearly every subtyped flu A virus in the U.S. and Canada is H1N1, a close relative of this year's vaccine strain. Here is what the numbers, the lab tests and the waning evidence say about timing your shot.

The billion-case forecast is three years old. What is new is a Lancet verdict on care, and the evidence on what helps a painful knee in your 50s or 60s.

Non-renewal notices, due by Oct. 2, are reaching about 390,000 UnitedHealthcare and 600,000 Humana members. The deadline most of them haven't heard about is March 4, 2027, the last day to apply for Medigap without health questions.

Headlines split on England's ADHD and autism review because the report says two things at once. Here is which sentences are findings, which are recommendations and which the government has promised.

WHO's first child and adolescent obesity guidelines pair firm advice with thin proof. Here are the grades behind each rule, the conditions on teen drug treatment, and questions to bring to a pediatrician.

The sneezing that waits until you're in bed has a real mechanism behind it — three of them, actually, and they compound.

The drowsiness that arrives every October has more to do with light than temperature, and the warm room may be doing more harm than the cold outside.

The exhaustion of fall allergy season has at least three sources, and the pill is only one of them. Here is how to tell which one is wearing you down.

Four years after the first Adderall shortage notice, the DEA has raised its national stimulant production quotas twice. The mechanism behind the gap that remains is bureaucratic, not dramatic.